MaxCyte Book Value Per Share from 2010 to 2024

MXCT Stock

USD 3.55 0.10 2.90%

MaxCyte Book Value Per Share yearly trend continues to be comparatively stable with very little volatility. Book Value Per Share is likely to outpace its year average in 2024. Book Value Per Share is the ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of MaxCyte according to its financial statements. View All Fundamentals

Book Value Per Share

First Reported

2010-12-31

Previous Quarter

2.24818793

Current Value

2.36

Quarterly Volatility

1.10996453

Credit Downgrade

Yuan Drop

Covid

Check MaxCyte financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among MaxCyte's main balance sheet or income statement drivers, such as Depreciation And Amortization of 4.4 M, Interest Expense of 138.6 K or Selling General Administrative of 31.6 M, as well as many indicators such as Price To Sales Ratio of 11.17, Dividend Yield of 0.0 or PTB Ratio of 2.2. MaxCyte financial statements analysis is a perfect complement when working with MaxCyte Valuation or Volatility modules.

Check out the analysis of MaxCyte Correlation against competitors.

For more information on how to buy MaxCyte Stock please use our How to Invest in MaxCyte guide.

Latest MaxCyte's Book Value Per Share Growth Pattern

Below is the plot of the Book Value Per Share of MaxCyte over the last few years. It is the ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of a company according to its financial statements. MaxCyte's Book Value Per Share historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in MaxCyte's overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 2.03 X

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Book Value Per Share

Timeline

MaxCyte Book Value Per Share Regression Statistics

	Arithmetic Mean	0.76
	Geometric Mean	0.19
	Coefficient Of Variation	146.88
	Mean Deviation	0.93
	Median	0.24
	Standard Deviation	1.11
	Sample Variance	1.23
	Range	2.972
	R-Value	0.82
	Mean Square Error	0.44
	R-Squared	0.67
	Significance	0.0002
	Slope	0.20
	Total Sum of Squares	17.25

MaxCyte Book Value Per Share History

	2024	2.36
	2023	2.25
	2022	2.5
	2021	2.9
	2020	0.48
	2018	0.24
	2017	0.4

Other Fundumenentals of MaxCyte

Tangible Book Value Per Share

MaxCyte Book Value Per Share component correlations

	Total Assets	Total Stockholder Equity	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Total Liab	Total Current Assets	Short Term Debt	Common Stock	Net Tangible Assets	Long Term Debt	Net Invested Capital	Short Long Term Debt	Net Working Capital	Property Plant Equipment	Short Term Investments	Capital Stock	Capital Surpluse
Total Assets		1.0	0.83	-0.64	-0.92	-0.4	0.8	0.91	0.99	-0.38	0.79	0.99	0.76	0.95	-0.6	0.94	0.94	0.94	0.96	0.69
Total Stockholder Equity	1.0		0.83	-0.64	-0.9	-0.4	0.79	0.89	0.99	-0.37	0.78	0.99	0.74	0.96	-0.58	0.95	0.93	0.95	0.96	0.67
Current Deferred Revenue	0.83	0.83		-0.57	-0.81	-0.2	0.93	0.8	0.87	-0.59	0.94	0.75	0.74	0.85	-0.21	0.85	0.73	0.86	0.9	0.39
Net Debt	-0.64	-0.64	-0.57		0.64	-0.1	-0.37	-0.57	-0.63	0.25	-0.65	-0.63	-0.59	-0.57	0.49	-0.55	-0.52	-0.51	-0.61	-0.46
Retained Earnings	-0.92	-0.9	-0.81	0.64		0.32	-0.77	-0.99	-0.86	0.36	-0.84	-0.91	-0.91	-0.8	0.71	-0.75	-0.96	-0.76	-0.91	-0.81
Accounts Payable	-0.4	-0.4	-0.2	-0.1	0.32		-0.15	-0.31	-0.36	0.02	-0.05	-0.45	-0.22	-0.41	0.32	-0.39	-0.49	-0.4	-0.49	-0.38
Net Receivables	0.8	0.79	0.93	-0.37	-0.77	-0.15		0.78	0.83	-0.47	0.9	0.7	0.7	0.8	-0.17	0.81	0.71	0.84	0.83	0.35
Total Liab	0.91	0.89	0.8	-0.57	-0.99	-0.31	0.78		0.85	-0.43	0.82	0.9	0.86	0.78	-0.71	0.74	0.96	0.76	0.89	0.79
Total Current Assets	0.99	0.99	0.87	-0.63	-0.86	-0.36	0.83	0.85		-0.42	0.81	0.96	0.7	0.97	-0.48	0.97	0.88	0.98	0.96	0.57
Short Term Debt	-0.38	-0.37	-0.59	0.25	0.36	0.02	-0.47	-0.43	-0.42		-0.5	-0.3	-0.11	-0.35	0.03	-0.39	-0.3	-0.41	-0.39	0.01
Common Stock	0.79	0.78	0.94	-0.65	-0.84	-0.05	0.9	0.82	0.81	-0.5		0.71	0.81	0.78	-0.26	0.76	0.72	0.76	0.85	0.48
Net Tangible Assets	0.99	0.99	0.75	-0.63	-0.91	-0.45	0.7	0.9	0.96	-0.3	0.71		0.74	0.93	-0.68	0.9	0.95	0.9	0.94	0.76
Long Term Debt	0.76	0.74	0.74	-0.59	-0.91	-0.22	0.7	0.86	0.7	-0.11	0.81	0.74		0.66	-0.59	0.6	0.82	0.6	0.79	0.73
Net Invested Capital	0.95	0.96	0.85	-0.57	-0.8	-0.41	0.8	0.78	0.97	-0.35	0.78	0.93	0.66		-0.36	0.99	0.84	0.98	0.95	0.58
Short Long Term Debt	-0.6	-0.58	-0.21	0.49	0.71	0.32	-0.17	-0.71	-0.48	0.03	-0.26	-0.68	-0.59	-0.36		-0.31	-0.75	-0.31	-0.5	-0.82
Net Working Capital	0.94	0.95	0.85	-0.55	-0.75	-0.39	0.81	0.74	0.97	-0.39	0.76	0.9	0.6	0.99	-0.31		0.79	0.99	0.93	0.48
Property Plant Equipment	0.94	0.93	0.73	-0.52	-0.96	-0.49	0.71	0.96	0.88	-0.3	0.72	0.95	0.82	0.84	-0.75	0.79		0.8	0.91	0.84
Short Term Investments	0.94	0.95	0.86	-0.51	-0.76	-0.4	0.84	0.76	0.98	-0.41	0.76	0.9	0.6	0.98	-0.31	0.99	0.8		0.92	0.46
Capital Stock	0.96	0.96	0.9	-0.61	-0.91	-0.49	0.83	0.89	0.96	-0.39	0.85	0.94	0.79	0.95	-0.5	0.93	0.91	0.92		0.66
Capital Surpluse	0.69	0.67	0.39	-0.46	-0.81	-0.38	0.35	0.79	0.57	0.01	0.48	0.76	0.73	0.58	-0.82	0.48	0.84	0.46	0.66

Click cells to compare fundamentals

About MaxCyte Financial Statements

MaxCyte shareholders use historical fundamental indicators, such as Book Value Per Share, to determine how well the company is positioned to perform in the future. Although MaxCyte investors may analyze each financial statement separately, they are all interrelated. The changes in MaxCyte's assets and liabilities, for example, are also reflected in the revenues and expenses on on MaxCyte's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.

	Last Reported	Projected for Next Year
Book Value Per Share	2.25	2.36
Tangible Book Value Per Share	2.25	2.36

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for MaxCyte Stock Analysis

When running MaxCyte's price analysis, check to measure MaxCyte's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MaxCyte is operating at the current time. Most of MaxCyte's value examination focuses on studying past and present price action to predict the probability of MaxCyte's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MaxCyte's price. Additionally, you may evaluate how the addition of MaxCyte to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC